Prescribing Information

Medication Purpose

Liraglutide Biocon injection contains Liraglutide, which helps control elevated blood sugar levels and may also assist in preventing heart disease by slowing down food passage through the stomach.

Important Usage Information

Patients may experience fluid loss due to side effects like vomiting or diarrhea, especially at the start of treatment, and should stay hydrated. Always consult a healthcare provider with any questions or concerns.

Possible Adverse Reactions

Hypoglycemia (low blood sugar)

In clinical trials, hypoglycemia was less frequent with liraglutide monotherapy compared to other treatments (e.g., glimepiride). Symptoms include cold sweats, paleness, headache, and trembling.

Injection site reactions

Mild reactions (e.g., pain, bruising) occurred in about 2% of patients in trials. Rotate injection sites to reduce chances of irritation.

Other common side effects

Severe Reactions

In rare cases, some may experience severe side effects. If unusual symptoms occur, contact a healthcare provider immediately.

Guidelines to Avoid Site Reactions

Following your healthcare provider’s instructions for proper injection technique and rotating injection sites can help minimize site reactions.

Common Side Effects

Important: The risk of hypoglycemia increases if used with sulfonylureas or insulin; in these cases, dose adjustments may be necessary.

Reporting Side Effects

If you experience any side effects, consult your doctor, pharmacist, or nurse.
Additionally, side effects can be reported directly through the Yellow Card
Scheme at www.mhra.gov.uk/yellowcard or by downloading the MHRA Yellow Card
app from the Google Play or Apple App Store. Additionally, you can also report
adverse events at https://pharmacovigilancesmv.biocon.com/